EMA recommends booster vaccine targeting COVID-19 subvariants for approval
The European Medicines Agency (EMA) on Monday (12 September) recommended the authorisation of an adapted bivalent vaccine targeting the Omicron subvariants BA.4 and BA.5 in addition to the original strain of SARS-CoV-2 as a booster shot.